SARA DENNING: Open Payments
NPI 1609825140 · FINDLAY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 26 payments from 9 companies in 2025. Trend: 2023 $313 · 2024 $372 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $144 |
| Novartis Pharmaceuticals Corporation | 4 | $99 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| GENZYME CORPORATION | 2 | $44 |
| LEO Pharma Inc. | 1 | $31 |
| Genentech USA, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
Products named: DUPIXENT, XOLAIR, NEFFY, AIRSUPRA, ADBRY, Rhapsido, HYQVIA, TEZSPIRE.
Industry payments across OH — which companies pay providers there.
